Grifols reported 11.2 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Capricor Therapeutics 2.76K 2.76K Dec/2022
Cara Therapeutics 27.77 117.09 Sep/2021
Esperion Therapeutics 129.79 129 Dec/2024
GlaxoSmithKline 11.15 0.29 Dec/2025
Grifols 11.2 1.08 Dec/2025
TherapeuticsMD 0.75 3.3 Mar/2023